Registration for participants and exhibitors is open on Wednesday afternoon as well, as is table top setup for exhibitors Times TBA.

An application has been made to the EACCME® for CME accreditation of this event

Register now!

Learning objectives

  • Improve your ability to treat glaucoma based on new research findings, drug and device development(s).
  • Introduce newest techniques, how it could affect previous best practices
  • Identify newest research and future directions
  • Updates on MIGS
  • Updates on newest and pipeline drugs and their underlying modes of action
  • Learn about the newest, often unpublished trabecular meshwork, optic nerve, uveal scleral & other outflow research
  • Discuss the implications of this new research on Glaucoma drug and device development
  • Promote increased opportunities for collaborative scientific research and publications, provide a collegial environment and encourage new investigators

Meet our internationally acclaimed faculty.

September 26, 2019
07:00-17:00 Registration open
09:00–18:30 Exhibition open
08:30–10.00 Session 1
1. Medical therapy of open angle glaucoma
John Samples
2. Concepts of proving neuroprotection
Richard Lee
3. Concept of trabecular protection from bromide to rho kinase inhibitor
Ernst Tamm
4. Finding the Ying and Yang of Rho with a blue native gel
Paul Knepper
10:00–10:30 Coffee Break at Exhibition area
10:30–12:00 Session 2
1. The vision of Dave Epstein: Why we need an outflow drug
Casey Kopczynski
2. Rho kinase inhibitors as a class: A multitude of biological effects
Dan Stamer
3. Rho kinase inhibitors in glaucoma: Basic science studies
Ernst Tamm
4. Rho kinase inhibitors in Japan
Casey Kopczynski
12:00-14:00 Lunch Break
14.00–15.30 Session 3
1. Clinical Studies on Netarsudil
Shan Lin
2. Approval of Netarsudil and initial experience with its clinical use in the US
Casey Kopczynski
3. Clinical studies on Netarsudil combined with a prostaglandin
Casey Kopczynski
4. Side effects of Netarsudil
Shan Lin
15:30–15:45 Coffee Break
15:45–17:15 Session 4
1. What will the future of glaucoma therapy be like? How many bottles?
John Samples
2. The far future of glaucoma therapy
Dan Stamer
3. Development time lines; availability of the class; what about similar classes such as the serine kinase class
Casey Kopczynski
Questions and answers
- All
Evening An Amsterdam spirited welcome reception at congress venue
September 27, 2019
07:00–18:00 Registration open
08.00–18:30 Exhibition open
08:30–10.00 Session 5
1. The genetics of glaucoma
John Samples
2. The biochemistry of trabecular and uveoscleral outflow
Ernst Tamm
3. The common themes in the biochemistry of glaucoma: Misfolded proteins, cytotoxicity and trabecular protection
John Samples
4. Glaucoma as a disease of perfusion IOP and intracranial pressure
Alon Harris
10:00–10:30 Coffee Break in exhibition area
10:30–12:00 Session 6
1. Mitochondria and glaucoma
Miriam Kolko
2. Glaucoma in Asia
Shan Lin
3. Global prevalence of glaucoma
Rupert Bourne
4. Angle closure treatment: Now and in the future
Shan Lin
5. The biology of exfoliation biochemistry glaucoma: Past and future
Ernst Tamm
12:00–14:00 Lunch Break
14:00-15:30 Session 7
1. The biology of pressure fluctuation in Glaucoma
Dan Stamer
2. Glaucoma and pressure fluctuation
Kaweh Mansouri
3. Corticosteroid induced glaucoma
Dan Stamer
4. Clinical evaluation of the optic nerve
Hans Lemij
15:30–15:45 Coffee Break
15:45–17:00 Poster walk session
Evening Various activity options will be offered to get to know Amsterdam, or go out and draw your own plans.
To be announced
September 28, 2019
07:00–15:00 Registration open
08.00–18:00 Exhibition open
08.30–10.00 Session 8
1. Foibles and flaws in OCT interpretation
Hans Lemij
2. Measuring the eye: angle and optic nerve
Shan Lin
3. OCT in diagnosis of glaucoma and its relationship to glaucoma
Ingrida Januleviciene
4. Visual field testing: New types, old types and the value of the 10–2 to evaluate the glaucoma patient
10.30–12.00 Session 9
1. Alternative molecules in the treatment of glaucoma
John Samples
2. Current and future role of fixed combination therapy in glaucoma
Tasos Konstas
3. Interventions to improve adherence in glaucoma
Tasos Konstas
4. The toxicity of ophthalmic preservatives
Andrew Tatham
12:00–14:00 Lunch Break
14.00–15.30 Session 10
1. Trabeculectomy modifications for success
2. Antimetabolites and glaucoma surgery
Tony Fea
3. The categories and future of MIGS
4. Subconjunctival to anterior chamber shunts
Andrew Tatham
15:30–15:45 Coffee Break
16:00–17:15 Session 11
1. Suprchroidal shunts
Tony Fea
2. Canal based surgery
Kaweh Mansouri
3. Improvements in cyclodestruction P3,G6 and Micropulse
Shan Lin
4. The future of neuroprotection
Richard Lee

Social Program

The social program is under development, but will contain:

  • Welcome reception in the congress venue on Thursday evening
  • Various optional activities in Amsterdam on Friday evening


Information about optional tours and local pearls will be posted closer to the congress dates.

Some Important Dates

July 1, 2019 Deadline early registration fee
June 15, 2019 Closing poster abstract submission (extended!)
June 22, 2019 Accepted poster abstracts notification (extended!)
September 1, 2019 Deadline regular registration fee

Kugler Publications

Kugler Publications

Postal address:
P.O. Box 20538
1001 NM Amsterdam
The Netherlands
Tel: +31 20 68 45 700